Paul V Viscuse

Paul V Viscuse

Mayo Clinic - Rochester / United States
Others
AD Scientific Index ID: 5429374
Mayo Clinic College of Medicine and Science
person_outline Paul V Viscuse's MOST POPULAR ARTICLES
1-) First line androgen deprivation therapy vs. chemotherapy for patients with androgen receptor positive recurrent or metastatic salivary gland carcinoma—a retrospective studyPV Viscuse, KA Price, JJ Garcia, DJ Schembri-Wismayer, ...Frontiers in oncology 9, 701, 2019482019
2-) Clinical considerations for the management of androgen indifferent prostate cancerJE Berchuck, PV Viscuse, H Beltran, A AparicioProstate cancer and prostatic diseases 24 (3), 623-637, 2021412021
3-) Integrative medicine in cancer survivorsPV Viscuse, K Price, D Millstine, A Bhagra, B Bauer, KJ RuddyCurrent opinion in oncology 29 (4), 235-242, 2017402017
4-) Case report: enfortumab vedotin for metastatic urothelial carcinoma: a case series on the clinical and histopathologic spectrum of adverse cutaneous reactions from fatal …PV Viscuse, ML Marques-Piubelli, MM Heberton, ER Parra, AY Shah, ...Frontiers in Oncology 11, 621591, 2021412021
5-) Incidence, diagnosis, and treatment of cardiac toxicity from trastuzumab in patients with breast cancerS Nowsheen, PV Viscuse, CC O’Sullivan, NP Sandhu, TC Haddad, ...Current breast cancer reports 9, 173-182, 2017392017